Advancing thromboprophylaxis in ambulatory high-risk cancer patients: addressing challenges and new insights from the TARGET-TP trial
Azzam Ali(Dow University of Health Sciences), Aymar Akilimali(Roslin Institute), Areeba Fareed(Karachi Medical and Dental College), Syed Muhammad Muneeb Akhtar(Dow University of Health Sciences), Syed Zia Saleem(Dow University of Health Sciences)
Cited by 0
Related Papers
Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
|Annals of Medicine and Surgery|2024|87
Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa
|Annals of Medicine and Surgery|2023|30
Self-medication and Anti-malarial Drug Resistance in the Democratic Republic of the Congo (DRC): A silent threat
|Tropical Medicine and Health|2022|29
Barriers Encountered Toward Pursuing a Neurosurgical Career: A Cross-Sectional Study Among Medical Students, Interns, and Junior Doctors in Africa
|World Neurosurgery|2022|26
The unmet need of organ transplantation in Africa
|International Journal of Surgery|2023|21